If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Keep me logged in Forgot your password?

Please wait...

Please wait...

 Androgen Deprivation

ADT Prior to Salvage Cryo Does Not Improve BFS

May 21, 2012

Androgen deprivation therapy (ADT) prior to salvage cryotherapy does not improve biochemical-free survival (BFS) at five years, according to data presented at the American Urological Association 2012 annual meeting.
 

Radiotherapy Added to ADT Beneficial

May 01, 2012

Adding radiotherapy to androgen deprivation therapy (ADT) improves outcomes in patients with locally advanced prostate cancer (PCa) and can be considered a standard treatment option.
 

BMD Loss Occurs Early in Androgen Deprivation Therapy

April 12, 2012

Study finds loss evident in men treated with ADT for nonmetastatic, hormone-sensitive prostate cancer
 

Benefits of Androgen Deprivation Therapy Discussed

March 01, 2011

The addition of androgen deprivation therapy (ADT) to escalated external beam radiotherapy may improve biochemical failure-free survival in men with intermediate-risk prostate cancer. However, the addition of ADT does not appear to provide an overall survival (OS) benefit.
 

Androgen Deprivation Therapy Linked to Colon Cancer

January 20, 2011

For the first time, androgen deprivation therapy for prostate cancer has been linked to an increased risk of colon cancer. John Schieszer has the story in today's Medical Minute.
 

Adding Hormone Therapy to Radiotherapy Aids Survival

January 15, 2010

Patients with intermediate-risk prostate cancer benefit from androgen suppression plus radiotherapy.
 

Fractures Increase Mortality Risk In Prostate Cancer Patients on ADT

November 19, 2009

BERLIN—Men with non-metastatic prostate cancer who begin androgen deprivation therapy (ADT) with vertebral fractures at baseline have shorter survival time compared with those free of baseline fractures.
 

Drug Raises Bone Mineral Density in ADT Recipients

September 28, 2009

In a study of prostate cancer patients, denosumab also decreased the risk of new vertebral fractures.
 

 

© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions